The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...

The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...

And other biotech news brought to you by The Readout.

"Comprehensive Review Highlights Market Growth, Innovation, and Investment Trends Driving the Future of Cell and Gene Therapy Tools, Biomanufacturing, and Gene Synthesis" BOSTON, June 20 ...

A British man has just become the first-ever patient to receive a therapy dubbed the ‘world’s most expensive drug’ outside of ...

BCC Research announces the release of its "2024 Cell and Gene: Research Review," which forecasts strong and steady growth across several key areas of the cell and gene therapy (CGT) industry. This ...

The Food and Drug Administration (FDA) announced a new crackdown Wednesday on the flow of American DNA to labs in ...

The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about ...

Beam Therapeutics shows promising BEACON trial results in SCD, backed by strong cash reserves and pipeline momentum. See why ...

Verve's top drug, Verve-102, is designed to target a gene called PCSK9, which is associated with heart health and cholesterol levels.

The European Commission had not received by Wednesday's deadline any remedies from Mars for its deal to take over the Pringles maker, which it agreed to buy last August. Executives vouch for the ...

Shares of the maker of the wildly popular Labubu dolls fell after a commentary by The People's Daily called for tighter regulation to protect minors from impulse purchases. The president gave the ...